Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.10    -0.10 (-0.13%)
Bid:
78.10
Ask:
78.25
Spread: 0.15 (0.192%)
Market Cap: £1.50b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

20 May 2026 07:00

RNS Number : 9800E
Coats Group PLC
20 May 2026
Β 

20 May 2026

Coats Group plc

AGM Trading Update

Robust performance year-to-date,

full-year expectations unchanged

Β 

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four month period 1 January to 30 April 2026 (the 'period') ahead of its Annual General Meeting to be held later today.

Β 

Continuing operations

1st January to 30th April 2026 revenue versus same period in 2025

Organic CER

Reported

Apparel

1%

1%

Footwear

(4)%

55%

Group

(1)%

Β 18%

Β 

Β 

All following references are at organic constant exchange rates (CER) unless specified.

Β 

The Group delivered a robust performance with revenue 1% lower against a solid pre-tariff comparator period.

Β 

Apparel revenue was up 1%, strongly outperforming the core thread end market, driven by our key differentiators of operational agility, enduring customer relationships and our global manufacturing capabilities. The division continues to win market share across its portfolio including in China domestic and also saw strong growth in automotive thread.

Β 

In line with our expectations, Footwear revenue was 4% lower on an organic basis, which we estimate to be inline with industry trends, as customer caution persisted and inventory levels remained low. OrthoLite revenue was lower than the same period last year on a proforma basis against a very strong prior year comparator and temporary capacity challenges in Indonesia, where we are expanding our footprint. Our plans to realise cost synergies are on track and we are increasingly positive on sales synergies. We remain confident in OrthoLite's growth prospects.

Β 

Group EBIT margin was slightly higher than the same period last year, reflecting the benefits of the 2025 footprint consolidation in Footwear and the positive contribution from OrthoLite.

Β 

While the ongoing tensions in the Middle East have not had a material impact on trading to date, we are monitoring conditions closely. We have promptly enacted our well-honed operational and commercial playbook ensuring optimal pricing and cost discipline. We will continue to take action as required to mitigate supply chain pressures and raw material and energy cost increases.

Β 

Outlook

Β 

The Group's full year outlook remains unchanged with a modest second half profit weighting due to expected inflation cost recovery timing.

Β 

We expect full year free cash flow generation to remain strong, enabling the Group to continue to reduce leverage into our target range of 1-2x by year-end.

Β 

Β 

The Group will release its interim results on Tuesday 28 July 2026.Β 

Β 

Β 

Enquiry details

Investors

Chris Dyett

Coats Group plc

+44 (0) 7974 974 690

Media

Nick Hasell / Victoria Hayns

FTI Consulting

+44 (0)20 3727 1340

About Coats Group plc

Β 

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

Β 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

Β 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2025, we generated $1.5 billion in revenue and employed c.19,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

Β 

LEI: 2138003SPYWGAITNFY17

Β 

Cautionary statement

Β 

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTAKCBNABKDNPD
Date   Source Headline
16th Oct 20094:21 pmRNSHolding(s) in Company
16th Oct 20094:08 pmRNSMMC Contrarian Limited
5th Oct 20093:38 pmRNSHolding(s) in Company
1st Oct 20093:24 pmRNSCompany Secretary Change
30th Sep 20094:45 pmRNSInterim Report Available on DVF
21st Sep 200910:50 amRNSHolding(s) in Company
17th Sep 200912:51 pmRNSDirector/PDMR Shareholding
11th Sep 200912:40 pmRNSDocument Viewing Facility
10th Sep 200910:50 amRNSPartial Takeover Offer for Tandou Ltd in Australia
3rd Sep 200911:48 amRNSChange of CEO at Coats
1st Sep 20093:17 pmRNSDirector/PDMR Shareholding
28th Aug 20095:01 pmRNSHalf Year Results of Coats Group Ltd 30.6.09
28th Aug 20094:47 pmRNSHalf Year Results to 30 June 2009
24th Aug 200912:00 pmRNSResponse to Shareholder Letter
17th Aug 200912:01 pmRNSHolding(s) in Company
14th Aug 20097:00 amRNSMarket Update
30th Jun 20093:56 pmRNSTotal Voting Rights
23rd Jun 20094:17 pmRNSChange of Director's Interests
22nd Jun 20095:19 pmRNSChange of Director's Interests
22nd Jun 200910:45 amRNSHolding(s) in Company
8th Jun 20093:33 pmRNSDirector/PDMR Shareholding
5th Jun 20095:22 pmRNSIssue of Equity
4th Jun 20093:23 pmRNSHolding(s) in Company
4th Jun 200910:19 amRNSHolding(s) in Company
29th May 20092:25 pmRNSTotal Voting Rights
28th May 200912:05 pmRNSDirectorate Change
26th May 20094:41 pmRNSNotification of Major Interest in Shares
22nd May 20093:36 pmRNSResult of AGM
21st May 20093:09 pmRNSDirector/PDMR Shareholding
18th May 20094:01 pmRNSDirector/PDMR Shareholding
18th May 20098:00 amRNSOfficial List Notice
15th May 20095:10 pmRNSScrip Dividend Alternative
15th May 200911:58 amRNSInterim Management Statement
15th May 20097:00 amRNSMarket Update
7th May 20094:13 pmRNSHolding(s) in Company
7th May 20094:05 pmRNSHolding(s) in Company
29th Apr 200911:44 amRNSHolding(s) in Company
28th Apr 20094:26 pmRNSAnnual Information Update
24th Apr 20097:00 amRNSResponse to Shareholder Letter
21st Apr 200910:41 amRNSAmendment to Capitalisation Issue Timetable
8th Apr 20095:11 pmRNSDocument Viewing Facility
31st Mar 20092:48 pmRNSTotal Voting Rights
31st Mar 20097:00 amRNSCirc re. Stock Events
31st Mar 20097:00 amRNSAnnual Report and Accounts
23rd Mar 20094:57 pmRNSDirector/PDMR Shareholding
16th Mar 20093:37 pmRNSNotification of Major Interests in Shares
13th Mar 200910:36 amRNSChange of AGM Date
3rd Mar 20094:53 pmRNSNotification of Major Interests in Shares
27th Feb 20097:00 amRNSCoats Group Final Results
27th Feb 20097:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.